Erkan YURTCU, Seda TÜRKOĞLU BABAKURBAN, Özlem YILMAZ ÖZBEK, Hakan AKKAŞ, Erdinç AYDIN

Effect of mometasone furoate nasal spray on the DNA of nasal mucosal cells

Background/aim: Allergic rhinitis (AR) is a respiratory disease caused by inflammation of the nasal mucosa. Intranasal corticosteroids(ICs) are an effective treatment for AR; however, their use has been associated with atrophy in nasal mucosae. Because DNA damagehas been linked to several chronic diseases, we hypothesize that use of ICs could cause DNA damage in nasal mucosa cells, leading tomucosal atrophy and septal perforation.Materials and methods: Sixty patients with moderate or severe AR were divided randomly into two groups. Mometasone furoate (MF)and antihistamine tablets (desloratadine) were given to the study (IC) group. Physiologic saline and desloratadine were given to thecontrol ((serum physiologic (SP)) group. Nasal irrigation fluid was taken from patients before study commencement and after 4 weeksof treatment. The comet assay was applied to detect DNA damage in nasal mucosa cells.Results: Nineteen patients were excluded, leaving a study population of 41 patients (IC group: 17 patients; SP group: 24 patients).Genotoxic damage was evaluated by comet assay.Conclusion: Treatment with MF spray for 4 weeks does not cause DNA breaks within cells in the nasal mucosa. These results could formthe basis of clinical trials involving treatment with different ICs over longer treatment periods.

PDF

___

Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: 147-334.
Keleş N, Ilicali C, Değer K. The effects of different levels of air pollution on atopy and symptoms of allergic rhinitis. Am J Rhinol 1999; 13: 185-190.
Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86: 494-507.
Cingi C, Songu M. Nasal steroid perspective: knowledge and attitudes. Eur Arch Otorhinolaryngol 2010; 267: 725-730.
Kalyoncu AF, Demir AU, Ozcakar B, Bozkurt B, Artvinli M. Asthma and allergy in Turkish university students: two cross sectional surveys 5 years apart. Allergol Immunopathol (Madr) 2001; 29: 264-271.
Ciprandi G, Pronzato C, Ricca V, Baqnasco M, Canonica GW. Evidence of ICAM-1 expression on nasal epithelial cells in acute rhinoconjunctivitis due to pollen exposure. J Allergy Clin Immunol 1994; 4: 738-746.
Minshall E, Ghaffar O, Cameron L, O’Brien F, Quinn H, Rowe-Jones J, Davies RJ, Prior A, Lund VJ, Mackay IS et al. Assessment by nasal biopsy after long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648-654.
Cervin A, Andersson M. Intranasal steroids and septum perforation – an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology 1998; 36: 128-132.
Bende M, Mark J. Long-term effects of topical corticosteroids in the nose. J Laryngol Otol 1992; 106: 810-812.
Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 2002; 22: 1458-1467.
Cervin A, Hansson C, Greiff L, Andersson M. Nasal septal perforations during treatment with topical nasal glucocorticosteroids are generally not associated with contact allergy to steroids. ORL J Otorhinolaryngol Relat Spec 2003; 65: 103-105.
Eweiss A, Dogheim Y, Hassab M, Tayel H, Hammad Z. VCAM1 and eosinophilia in diffuse sino-nasal polyps. Eur Arch Otorhinolaryngol 2009; 266: 377-383.
Verret DJ, Marple BF. Effect of topical nasal steroid sprays on nasal mucosa and ciliary function. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 14-18.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Toqias A, Zuberbier T, Baena-Caqnani CE, Canonica GW, van Weel C. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63(Suppl 86): 8-160.
do Amaral RJ, Pedrosa Cda S, Kochem MC, Silva KR, Aniceto M, Claudio-da-Silva C, Borojevic R, Baptista LS. Isolation of human nasoseptal chondrogenic cells: a promise for cartilage engineering. Stem Cell Res 2012; 8: 292-299.
Koehler C, Ginzkey C, Friehs G, Hackenberg S, Froelich K, Scherzed A, Burghartz M, Kessler M, Kleinsasser N. Aspects of nitrogen dioxide toxicity in environmental urban concentrations in human nasal epithelium. Toxicol Appl Pharmacol 2010; 245: 219-225.
Yurtcu E, Iseri OD, Sahin FI. Effects of ascorbic acid and β-carotene on HepG2 human hepatocellular carcinoma cell line. Mol Biol Rep 2011; 38: 4265-4272.
Dinçer Y, Kankaya S. Comet assay for determining of DNA damage: review. Turkiye Klinikleri J Med Sci 2010; 30: 1365- 1373.
Green MH, Lowe JE, Delaney CA, Green IC. Comet assay to detect nitric oxide-dependent DNA damage in mammalian cells. Methods Enzymol 1996; 269: 243-266.
Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 2004; 26: 249-261.
McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 1993; 288: 47-63.
İşeri ÖD, Yurtcu E, Sahin FI, Haberal M. Corchorus olitorius (jute) extract induced cytotoxicity and genotoxicity on human multiple myeloma cells (ARH-77). Pharm Biol 2013; 51: 766- 770.
Rosenblut A, Bardin PG, Muller B, Faris MA, Wu WW, Caldwell MF, Fokkens WJ. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 2007; 62: 1071-1077.
Kim KT, Rabinovitch N, Uryniak T, Simpson B, O’Dowd L, Casty F. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Ann Allergy Asthma Immunol 2004; 93: 61- 67.
Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007; 62: 1078-1084.
Barton BE, Jakway JP, Smith SR, Siegel MI. Cytokine inhibition by a novel steroid: mometasone furoate. Immunopharmacol Immunotoxicol 1991; 13: 251-261.
Onrust SV, Lamb HM. Mometasone furoate. A review of its intranasal use in allergic rhinitis. Drugs 1998; 56: 725-745.
Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995; 95: 1097- 1110.
Van Henke E, Temmerman L. Contact allergy to the corticosteroid budesonide. Contact Dermatitis 1980; 6: 509.
Garzaro M, Pecorari G, Pezzoli M, Arrondini M, Novero D, Nadalin J, Giordano C. Mucous membrane plasmacytosis of the nose in a patient affected by B-cell chronic lymphocytic leukemia. Eur Arch Otorhinolaryngol 2009; 266: 1651-1654.
Product information for Nasonex® aqueous nasal spray 0.05% alcohol free (serial online). Available online at: www.medicines. org.au/files/mkpnanua.pdf; accessed 12 October 2016.
Scadding G, Erkan AN, Chau H, Maskell S. Audit of nasal steroid use and effectiveness in a rhinitis clinic. Expert Rev Pharmacoecon Outcome Res 2010; 10: 87-90.
Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 2007; 28: 145-152.
Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol 2003; 117: 843-845.
Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther 1997; 19: 27-38.
Minshall E, Ghaffar O, Cameron L, O’Brien F, Quinn H, RoweJones J, Davies RJ, Prior A, Lund VJ, Mackay IS. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648-654.
Pipkorn U, Pukander J, Suonpää J, Mäkinen J, Lindqvist N. Long-term safety of budesonide nasal aerosol: a 5.5-year follow-up study. Clin Allergy 1998; 18: 253-255.
Güngör A, Poyrazoğlu E, Yıldırım Ş, Basutcu S, Candan H. The effect of budesonide that is the topical corticosteroid on the rat nasal mucosa (experimental study). Turk Arch Otorhinol 2002; 40: 23-27.
Kridel RWH. Considerations in the etiology, treatment and repair of septal perforations. Facial Plast Surg Clin North Am 2004; 12: 435-450.
Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol 2012; 22: 1-12.
Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung 1998; 948: 956-960.
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyame Y, Rojas E, Ryu JC, Sasak, YF. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Mutat Res 2000; 35: 206-221.
Forchhammer L, Bräuner EV, Folkmann JK, Danielsen PH, Nielsen C, Jensen A, Loft S, Friis G, Møller P. Variation in assessment of oxidatively damaged DNA in mononuclear blood cells by the comet assay with visual scoring. Mutagenesis 2008; 23: 223-231.